✔ 100% Authentic Product
👁️ Currently Viewing 311
Dasacent 100mg Tablet 1 Strip
Dasacent is a medication primarily used for treating Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in both adult and pediatric patients.
- Adults:
- Newly diagnosed Ph+ CML in chronic phase.
- Chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy.
- Ph+ ALL with resistance or intolerance to prior therapy.
- Pediatric patients (1 year and older):
- Ph+ CML in chronic phase.
- Newly diagnosed Ph+ ALL in combination with chemotherapy.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cash on Delivery - All over Bangladesh
Regular Delivery - 8-12 Hours, Dhaka City*- Regular Delivery - 24-48 Hours, All Over Bangladesh*
ফ্রি ডেলিভারি! - ১৪৯৯ টাকা+ অর্ডারে ঢাকা
শহরে ।- ফ্রি ডেলিভারি! - ২৯৯৯ টাকা+ অর্ডারে ঢাকার
বাহিরে ।
✅ Description:
- Mechanism of Action: Dasatinib inhibits several kinases including BCR-ABL, SRC family, c-KIT, EPHA2, and PDGFRβ. This inhibition helps overcome Imatinib resistance and targets various signaling pathways involved in leukemia progression.
- Absorption: Peak plasma concentrations are reached between 0.5 to 6 hours after oral administration.
- Metabolism: Primarily metabolized by CYP3A4, with minor contributions from other enzymes like FMO-3 and UGT.
- Excretion: Mostly excreted in the feces, with only 4% excreted in urine.
Relevant Products / প্রাসঙ্গিক পণ্য
✔️ Side Effects
- Common side effects include myelosuppression, bleeding events, fluid retention, cardiovascular issues, pulmonary arterial hypertension, QT prolongation, and severe dermatologic reactions like Stevens-Johnson syndrome.
✔️ Dosage & Administration
- Adult Dosage:
- Chronic Phase CML: 100 mg orally once daily.
- Accelerated phase, blast phase CML, or Ph+ ALL: 140 mg orally once daily.
- Pediatric Dosage:
- Based on weight (starting from 40 mg/day for children weighing 10-20 kg, to 100 mg/day for those weighing 45 kg or more).
✔️ Interactions
- CYP3A4 Inhibitors: Can increase Dasacent concentrations and may raise the risk of toxicity.
- CYP3A4 Inducers: Can decrease Dasacent concentrations and reduce efficacy.
- Gastric Acid Reducing Agents: May reduce Dasacent's effectiveness; avoid use with H2 antagonists or proton pump inhibitors.
✔️ Pregnancy & Lactation
- Pregnancy: Dasatinib can cause fetal harm and should not be used during pregnancy unless necessary.
- Breastfeeding: Not recommended due to excretion in breast milk.
✔️ Precautions
- Myelosuppression: Regular blood count monitoring is required, especially in advanced disease stages.
- Bleeding: Monitor for hemorrhage risks, especially if on anticoagulants.
- Pulmonary Arterial Hypertension (PAH): Patients should be monitored for PAH, which may require discontinuation of treatment.
- QT Prolongation: Risk in patients with electrolyte imbalances or on other QT-prolonging drugs.
✔️ Storage
- Store below 30°C in a dry place, away from light, and out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.
